LVAD DT denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for lvad dt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies LVAD Destination Therapy on Medical-Necessity Grounds

Aetna's medical-necessity denials for LVAD destination therapy typically arise when the clinical file does not clearly establish that the patient meets all criteria in Aetna's Clinical Policy Bulletin for LVAD-DT. LVAD-DT is reserved for patients with advanced, end-stage heart failure who are not candidates for cardiac transplantation and who meet specific functional and clinical criteria. The denial does not mean the patient does not need the device — it means the documentation submitted to Aetna did not yet demonstrate that all criteria are satisfied to the reviewer's standard. Given that LVAD-DT is a life-sustaining intervention, this denial warrants urgent appeal.

## Why This Denial Is Appealable

Medical-necessity denials for LVAD-DT are routinely appealed and reversed when the clinical documentation is complete and properly organized. ACA §2719 provides access to external review by an Independent Review Organization. ERISA §503 requires full-and-fair review for employer-sponsored plans. File an internal appeal within the deadline on the denial notice — and given the life-sustaining nature of LVAD-DT, request expedited (72-hour) review at both the internal and external stages on the grounds that delay would seriously jeopardize the patient's health or life. External review must be requested within approximately four months of exhausting internal remedies.

## The Concrete Appeal Process

1. Obtain Aetna's Clinical Policy Bulletin for LVAD/mechanical circulatory support — this document contains every criterion the reviewer applied. 2. Identify each unmet criterion cited in the denial letter. 3. Assemble documentation addressing every unmet criterion (see below). 4. File an urgent internal appeal with the complete clinical package. 5. Request expedited external IRO review if the internal timeline creates clinical risk.

## Documentation to Gather

• Advanced heart failure diagnosis: chart notes from the treating cardiologist and/or heart failure specialist confirming the diagnosis, disease stage per the applicable classification system (reference the guideline organization, not specific numbers), and disease trajectory.
• Transplant ineligibility: a formal transplant evaluation report or equivalent documentation from a transplant center confirming the patient is not a transplant candidate, with documented clinical reasons.
• Functional status documentation: chart notes describing the patient's functional class and clinical deterioration, referencing the applicable heart failure classification used by the treating team.
• Prior therapy history: documentation of advanced medical therapies that have been optimized or tried, with dates and clinical outcomes.
• Cardiology team's medical-necessity letter: a comprehensive letter from the treating heart failure specialist or cardiac surgeon walking through each criterion in Aetna's Clinical Policy Bulletin and citing the specific chart evidence that satisfies it.
• FDA-approved device labeling: the approved indication for use from the device's FDA labeling.

## Criteria-Mapping Structure

Copy every criterion from Aetna's Clinical Policy Bulletin into a table. For each criterion, cite the specific chart document, date, and clinical finding that satisfies it. For transplant ineligibility, attach the formal evaluation report. For functional status, cite the specific chart note and the assessment date. For prior therapy optimization, list each therapy with dates and documented outcomes. This one-to-one mapping is the most effective format for a LVAD-DT medical-necessity appeal and is the format external IRO reviewers expect.